Topelia is a public, unlisted biotechnology company that has initiated preparations for a Phase 3 trial of its dedicated to Antiviral Triple Therapy (ATT), TPL101, initially targeting coronavirus infections. Building upon their success in commercialising a Triple Therapy for Helicobacter pylori, Top...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2021 (4 years)
Address:
1/229 GREAT NORTH RD; FIVE DOCK, NEW SOUTH WALES 2046, AU
LOW
spending power
